Skip survey header

9085 ISTH LLS 2021 Enduring

Preparing for Practice Readiness in Gene Therapy for Hemophilia

Which of the following statements about GTH is incorrect? *This question is required.
Which of the following is an exclusion criterion for all patients participating in GTH clinical trials?     *This question is required.
Which of the following post-infusion adverse events is most likely in patients who receive GTH? *This question is required.
Which of the following will need to be monitored on a regular 3-4 month basis indefinitely following vector infusion? *This question is required.